Stock REPCF REPLICEL LIFE SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart RepliCel Life Sciences Inc.

Equities

REPCF

CA76027P4006

Market Closed - OTC Markets
Other stock markets
 15:20:42 15/03/2024 GMT 		5-day change 1st Jan Change
0.0428 USD +4.99% Intraday chart for RepliCel Life Sciences Inc. -.--% -4.89%
05-31 RepliCel Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-17 RepliCel Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
REPLICEL LIFE SCIENCES INC. Stock RepliCel Life Sciences Inc.
 2.78M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.82B -
ARGENX SE Stock argenx SE
 22.48B -
GENMAB A/S Stock Genmab A/S
 18.32B
  1. Stock Market
  2. Equities
  3. REPCF Stock
  4. Charts RepliCel Life Sciences Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW